49 research outputs found

    Entecavir (ETV) demonstrates consistent responses throughout baseline disease and demographic subgroups for the treatment of lamivudine-refractory HBeAg(+) patients with chronic hepatitis B

    No full text
    41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver -- APR 26-30, 2006 -- Vienna, AUSTRIAWOS: 000237328100512European Assoc Study Live
    corecore